insights_auto
Why is SYK up 3.24%?
Dive Deeperchevron_right
SYK:NYSE
Stryker Corp
$ 290.76
arrow_upward
+3.24%(+9.13) 1D
10-р сарын 15, 11:17:35 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SYK...
Open
$ 287.00
High
$ 291.37
Low
$ 286.55
Mkt. cap
111.53Т
Avg. vol.
2.90 сая
Volume
697.88 мян
Dividend
1.21%
Quarterly dividend
$ 0.88
Ex-dividend date
2026 оны 9-р сарын 30
P/E ratio
30.13
52-wk high
$ 392.55
52-wk low
$ 267.00
EPS
$ 9.65
Beta
0.77
Shares outstanding
383.57 сая
No. of employees
56 мян
Open
$ 287.00
High
$ 291.37
Low
$ 286.55
Mkt. cap
111.53Т
Avg. vol.
2.90 сая
Volume
697.88 мян
Dividend
1.21%
Quarterly dividend
$ 0.88
Ex-dividend date
2026 оны 9-р сарын 30
P/E ratio
30.13
52-wk high
$ 392.55
52-wk low
$ 267.00
EPS
$ 9.65
Beta
0.77
Shares outstanding
383.57 сая
No. of employees
56 мян
News stories
From web sources and news partners
PR Newswire
·
1 цагийн өмнө
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK
Quiver Quantitative
·
5 цагийн өмнө
Fund Update: 193,420 STRYKER (SYK) shares added to FORT WASHINGTON INVESTMENT ADVISORS INC |OH| portfolio
Today's Medical Developments
·
9 цагийн өмнө
Major medtech business moves from Stryker, STERIS
Zacks
·
21 цагийн өмнө
ISRG Gains Nearly 12% in a Month: Should You Buy, Hold or Sell?
Profile
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000. Wikipedia
About Stryker Corp
CEOKevin A. Lobo
Employees56 мян
Founded1941
HeadquartersКаламазоо, Мичиган, Америкийн Нэгдсэн Улс
Sector-
Websitestryker.com